Monday, October 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· April 25, 2026

BitsStrategy Launches Free Day Trading Bot App for Fully Automated Quantitative Trading

View original at globenewswire.com
BitsStrategy Launches Free Day Trading Bot App for Fully Automated Quantitative Trading — A Three-Step Process Makes Intelligent Day Trading More Accessible to Modern Market Participants NEW YORK, April 25, 2026 (GLOBE NEWSWIRE) -- As financial markets continue to evolve at a rapid pace, more traders are looking for ef…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • BitsStrategy sees strong long-term potential in intelligent trading tools as users continue to seek smarter ways to navigate increasingly dynamic markets.

    60% confidence
  • The day trading bot app can automatically execute trades based on the platform's quantitative strategy logic, helping users capture intraday opportunities and pursue potential returns once a plan is activated.

    60% confidence
  • Technology can help simplify the day trading experience for a wider group of users. The free day trading bot app aims to provide a more convenient way for users to access automated quantitative trading tools and benefit from intelligent execution capabilities.

    60% confidence
  • Industry observers note that traders are increasingly attracted to tools that can help reduce manual workload, improve responsiveness, and create more consistent trading processes.

    60% confidence
  • The free day trading bot app launch reflects BitsStrategy's continued commitment to expanding access to intelligent trading technology by combining AI-based analysis with automated execution.

    60% confidence
  • BitsStrategy will continue investing in AI trading technology, quantitative strategy development, and user experience improvements to deliver more efficient, stable, and accessible trading solutions for users worldwide.

    60% confidence
  • Fully automated quantitative trading tools may play an increasingly important role in the future of modern trading as artificial intelligence and automation become more deeply integrated into financial services.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com